Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for December 2008
December 1, 2008
- Introgen Restructures Operations to Focus on Revenue-Generating Manufacturing Capabilities
- Quintiles Acquires Targeted Molecular Diagnostics
- Arpida to Restructure and Focus on Key Projects
- Hemispherx Biopharma Introduces Expense Reduction Program
- Johnson & Johnson Announces Definitive Agreement to Acquire Mentor Corporation
- TargetRx's LaunchAdvantage Offers Critical Insight for Successful Drug Introductions
- Pressure BioSciences, Inc. Announces Restructuring, Significant Cost Reduction Initiatives, and Sharpened Focus
- Enzon Discontinues Its Plan to Spin-off Its Biotechnology Business
December 2, 2008
- InSite Vision Announces Corporate Restructuring To Focus on Growth Opportunities and Conserve Resources
- WuXi PharmaTech Will Focus U.S. Operations on Laboratory Testing Services
- Titan Pharmaceuticals Announces Reduction in Force
- Sinovac Releases Statement on Healive Vaccine Suspension
- Epilepsy Drug May Increase Risk of Autism in Children
- PhRMA Statement on JAMA Study
- Brand-Name Drugs Do Not Appear Superior to Generic Drugs for Treating Cardiovascular Disease
December 3, 2008
- FDA Issues Questions and Answers on Medication Guides for Erythropoiesis-stimulating Agents (ESAs).
- Innohep (tinzaparin): Clinical study Stopped Early Because of Interim Finding of Increased All-cause Mortality in Patients Who Received Drug
- Cell Genesys and Takeda Announce Termination of Collaboration Agreement for GVAX Immunotherapy for Prostate Cancer
- Drug Marketing Techniques May Be Risking Patient Safety
- AstraZeneca Appoints Graham Baker Vice President and Chief Financial Officer for North America
- The Prescription Project Petitions FDA to Order Pharmaceutical and Medical Device Companies to Remove Illegal Internet Ads
December 4, 2008
- GlaxoSmithKline Announces Waiver of a Condition to the Tender Offer for Genelabs Technologies, Inc.
- ThermoGenesis Announces Management Transition; Provides Update on Operational Milestones
- Merck Provides 2009 Financial Guidance; Reaffirms Guidance for 2008 and 2010
- Introgen Files Voluntary Chapter 11 Petition to Facilitate Restructuring
- Forest Laboratories Responds to Unsolicited Mini-Tender Offer
- Economic Measures Including a Projected Corporate Restructuring and Workforce Reduction
December 5, 2008
- FDA Sends AstraZeneca Letter about Seroquel
- YM BioSciences Provides EU Regulatory Update
- Novel Basis Identified for Tamoxifen Failure
December 8, 2008
- Bristol-Myers Squibb and AstraZeneca Announce Expansion of Worldwide Collaboration to Develop and Commercialize Dapagliflozin in Japan
- SDI Reports: Physicians Satisfied with Number of Sales Rep Visits
- Alnylam Strengthens Intellectual Property Estate through Acquisition of Nucleonics Patent Assets
- FDA Approves GlaxoSmithKline Tetanus, Diphtheria, Whooping Cough Vaccine, Boostrix, for Adults
- Emisphere Announces Reorganization Plan to Strengthen Financials and Focus On Technology Application
December 9, 2008
- XTL Biopharmaceuticals Implements Restructuring Plan
- Electronic Prescribing System May Encourage Physicians to Choose Lower-Cost Drugs
- Kuvan Receives Marketing Approval in the European Union
- Merck KGaA’s Kuvan Receives Marketing Authorization in Europe
- Merck Outlines Long-Term Prospects and Progress on Strategic Plan at 2008 Annual Business Briefing
December 10, 2008
- Sanofi-Aventis: Changes in Organisation
- Popular Class of Diabetes Drugs Doubles Risk of Fractures in Women
- IMS Health Reports Annual Global Generics Prescription Sales Growth of 3.6 Percent, to $78 Billion
- America’s Pharmaceutical Research Companies Enhance Voluntary Guidelines on Direct-to-Consumer Advertising
- NRC Staff Proposes $3,250 Fine for Security Violations at GlaxoSmithKline Biologicals
December 11, 2008
- Hospira Issues Voluntary Recall of One Lot of 20meq Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection, USP Due to Incorrect Bar Code Label
- Hovione Buys Pfizer's Loughbeg API Facility
- Panacos Provides Update on Corporate Strategy
- AstraZeneca Returns Worldwide Rights to IPI-504 and IPI-493 Development Programs to Infinity Pharmaceuticals
- Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance
- The Prescription Project Criticizes New PhRMA DTCA Guidelines
- Dingell, Stupak React to PhRMA's DTC Policy Revisions
- Massachusetts Proposes Sweeping New Rules Governing Sales and Marketing Tactics of Pharmaceutical and Medical Device Companies
- Pain Therapeutics Receives Complete Response Letter From FDA for Remoxy
December 12, 2008
- FDA Requires New Safety Measures for Oral Sodium Phosphate Products to Reduce Risk of Acute Kidney Injury
- AstraZeneca Responds to FDA Joint Advisory Committees' Recommendation on Symbicort
- Elan Announces Resource Realignment
- GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
- Johnson & Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of Omrix
- Bayer Strengthens Research and Development
- AstraZeneca Responds to FDA Joint Advisory Committees’ Recommendation on Symbicort
- Amorfix Receives Fourth Biogen Idec Investment
- Johnson & Johnson Begins Tender Offer to Acquire Mentor Corporation
- Allergists Respond to FDA Committee Recommendation on Asthma Medication, Encourage Patients with Questions to Contact Physicians
- Sanofi-Aventis and Bristol-Myers Squibb Prevail before the U.S. Court of Appeals for the Federal Circuit in the U.S Plavix Patent Infringement Case
- Lilly Chairman Taurel Says Promise of Personalized Medicine Could be Jeopardized by Short-Sighted Public Policies
December 15, 2008
- Senator Grassley’s Letter to Wyeth About Medical Ghostwriting
- Senator Grassley’s letter to DesignWrite Inc. about medical ghostwriting
- Adventrx Exploring Strategic Options
- SDI Reports: Number of Flu Vaccines Given in Physicians’ Offices Lower This Season
- Sanofi-aventis U.S. Announces Increased Access to Drugs for Low Income Patients Through Expanded PAP Programs
- Titan Pharmaceuticals Announces Further Reductions in Workforce and Voluntary Delisting from the American Stock Exchange
- EntreMed Focuses on Development of ENMD-2076
- Major Shareholder Jack W. Schuler Calls for Termination of Elan CEO
December 16, 2008
- Akorn, Inc. Responds to FDA Draft Guidance for Industry on Bioequivalence Recommendation for Vancomycin HCl
- FDA signs contract with Entelos to Predict Cardiovascular Adverse Events
- Jazz Pharmaceuticals Announces Reduction in Force to Reflect Streamlined Operations
- Biogen-Idec Reports PML Case
December 17, 2008
- Abbott Exercises Its Option to Acquire Ibis Biosciences, a Subsidiary of Isis
- Healthcare Costs Prevented Nearly 40 Million Americans From Filling Their Prescriptions in 2008
- Neurobiological Technologies Announces Viprinex Does Not Pass Interim Futility Analysis
- National Survey Finds That in the Last Three Months Millions of Americans Are Stretching Their Drug Prescriptions, Saving Themselves Money, by Either Taking the Medication Less Often or by Taking a Smaller Dosage Than the Physician Prescribed
- FDA Requires Warnings about Risk of Suicidal Thoughts and Behavior for Antiepileptic Medications
- Study Finds Much of Private-Sector Consumer Medication Information Not Consistently Useful
- Lundbeck Initiates Clinical Phase III Trials With Desmoteplase in Ischemic Stroke
- FTC Sues Ovation Pharmaceuticals for Illegally Acquiring Drug Used to Treat Premature Babies with Life-Threatening Heart Condition
December 18, 2008
- Wyeth Pharmaceuticals Acquires Thiakis Limited
- FDA Announces New Recommendations on Evaluating Cardiovascular Risk in Drugs Intended to Treat Type 2 Diabetes
- ViroPharma Files FOIA Complaint Seeking Administrative Record for Vancocin
December 19, 2008
- Dynavax Announces Termination of Partnership With Merck for HEPLISAV Hepatitis B Vaccine
- ArQule Provides Update on Early-Stage Pipeline
- Targanta Announces Corporate Restructuring
- Oncothyreon Announces Development Plans and Personnel Changes and Updates Financial Guidance
December 22, 2008
- King Extends Tender Offer for Alpharma
- GlaxoSmithKline to Cease Providing Corporate Political Contributions
- GSK to Acquire BMS Pakistan
- Avigen Board and Management Comment On the Company's Strategic Plans
December 23, 2008
- GlaxoSmithKline and Archemix Form Strategic Alliance to Develop Aptamers to Treat Inflammatory Diseases
- Wisconsin AG Van Hollen Announces Settlement In Case Against Amgen And Immunex Alleging Deceptive Manipulation Of Average Wholesale Price For Pharmaceuticals
- Emory University Announces Actions Following Investigation
- Rep. Barton Probes FDA Contract
- Teva Completes Acquisition of Barr
- New Report Highlights Dramatic Change in U.S. Drug Spending Trends, Policy Implications
- KV Pharmaceutical Voluntarily Suspends All Shipments of Its Approved Tablet-Form Drugs
- Ethex Corporation Initiated Nationwide Voluntary Recall of a Single Lot of Hydromorphone HCl 2 mg Tablets Due to Potential for Oversized Tablet
- Abbott and Isis Announce Hart-Scott-Rodino Clearance of Abbott's Acquisition of Ibis Biosciences, a Subsidiary of Isis
December 24, 2008
- FDA Sends Abbott Letter About Humira
- Cytokinetics Retains Development and Commercialization Rights to Ispinesib and SB-743921
- CPI Investigates: Heart Drug Called 'Prima ry Suspect' in 667 Deaths
- Among Older Adults, Prescription And Over-The-Counter Medications Are Commonly Used Together
December 30, 2008
- Florida to Receive $8.5 Million in Medicaid Settlement with Pharmaceutical Company
- Biovail Announces Voluntary Recall of Certain Lots of Ultram ER 100mg Tablets
- King Completes Acquisition of Alpharma
- Actavis Acquires Kadian; Extends Specialty Drug Portfolio in U.S.
